EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014

Jun Wei, Yang Liu iD, Ya Li iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Jun Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jilin Medical University, Jilin, China. Hauptthemen laut MEDLINE: Methylmalonic Acid, Neurofilament Proteins, Mitochondrial Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Serum neurofilament light chain (sNfL) is an emerging biomarker of neuronal damage in various neurological disorders. Methylmalonic acid (MMA) serves as a biomarker for mitochondrial dysfunction. This study aimed to investigate the relationship between MMA and sNfL.

Methods

Data were obtained from the 2013–2014 National Health and Nutrition Examination Survey (NHANES). Multiple linear regression modeling was employed to confirm the association between MMA and sNfL, while smooth curve fitting was utilized to explore the potential nonlinear relationship. Subgroup analyses and interaction tests were conducted to assess the stability of the association across different subgroups.

Results

This study included 2,070 participants with a mean age of 46.89 ± 15.36 years. In the fully adjusted model, each 1 nmol/L increase in serum MMA was associated with a 3.11 pg/mL increase in sNfL (95% CI: 0.91 to 5.31; p = 0.0056). Participants in the highest quartile of MMA had significantly higher sNfL levels compared to those in the lowest quartile (β = 5.09; 95% CI: 2.30 to 7.87; p = 0.0004). A nonlinear relationship was observed, with an inflection point at 5.51 nmol/L of MMA, while above the threshold, MMA was strongly associated with higher sNfL levels (β = 12.57, 95% CI: 7.14 to 17.99; p < 0.0001). Subgroup analyses further suggested stronger associations among individuals with diabetes or low vitamin B12 status (P for interaction < 0.05).

Conclusions

Our study found a significant positive association between serum MMA and sNfL. Further prospective studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylmalonic AcidNeurofilament ProteinsMitochondrial DiseasesHumansFemaleMaleMiddle AgedCross-Sectional StudiesBiomarkersAdultNutrition SurveysUnited StatesAgedMitochondria

Stichwörter der Autor:innen

NHANESassociationserum methylmalonic acidserum neurofilament light chain

Substanzen

Methylmalonic AcidBiomarkersNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Jilin Medical University, Jilin, China.
  • Edinburgh Medical School: Biomedical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.
  • Zhejiang University School of Medicine, Zhejiang University-University of Edinburgh Institute, Haining, China.

ORCID-Profile: Yang Liu, Ya Li

Zitieren

APA

Wei, J., Liu, Y., & Li, Y. (2025). Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014. Brain and Behavior. https://doi.org/10.1002/brb3.70775

Vancouver

Wei J, Liu Y, Li Y. Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014. Brain and Behavior. 2025. doi:10.1002/brb3.70775

BibTeX
@article{Wei2025,
  author = {Wei, Jun and Liu, Yang and Li, Ya},
  title = {Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70775}
}
Kostenlos starten →